Evidence map›Paper›PMID 37538176›Full record

ArticleFrontiers in pharmacology2023

Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma.

Ao Zhang, Zhen Guo, Jia-Xin Ren, Hongyu Chen, Wenzhuo Yang, Yang Zhou, Lin Pan, Zhuopeng Chen, Fei Ren, Youqi Chen and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. The inhibitory effects ofIn silico pharmacology · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Ao ZhangDepartment of Neurology, The First Hospital of Jilin University, Changchun, China.
Zhen GuoDepartment of Cardiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Jia-Xin RenDepartment of Neurology, Stroke Center, The First Hospital of Jilin University, Changchun, China.
Hongyu ChenDepartment of Neurosurgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Wenzhuo YangDepartment of Neurosurgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Yang ZhouClinical College, Jilin University, Changchun, China.
Lin PanClinical College, Jilin University, Changchun, China.
Zhuopeng ChenDepartment of Neurosurgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Fei RenClinical College, Jilin University, Changchun, China.
Youqi ChenClinical College, Jilin University, Changchun, China.
Menghan ZhangDepartment of Clinical Laboratory, The Fifth Affiliated Hospital of Xinxiang Medical College, Xinxiang, China.
Fei PengDepartment of Medicine, Division of Endocrinology, Diabetes and Metabolism, Baylor College of Medicine, Houston, TX, United States.
Wanting ChenClinical College, Jilin University, Changchun, China.
Xinhui WangDepartment of Hematology, The First Clinical Medical School of Lanzhou University, Lanzhou, Gansu, China.
Zhiyun ZhangDepartment of Plastic Surgery, The First Hospital of Jilin University, Changchun, China.
Hui WuDepartment of Ophthalmology, First Hospital of Jilin University, Changchun, China.
Jilin University · CNSun Yat-sen University Cancer Center · CNFirst Hospital of Jilin University · CNBaylor College of Medicine · USLanzhou University · CNThe First Affiliated Hospital, Sun Yat-sen University · CNXinxiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

glioblastoma (GBM)MCL-1molecular dockingnomogramvirtual screening

Identifiers

PMID37538176
PMCPMC10394558
OpenAlexW4384828261

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.